IGHE and immunoglobulin G4-related sclerosing disease: Patients’ clinical symptoms alleviated, IgG4‐RD RI and PGA decreased, as well as reduction of laboratory parameters including serum IgG, IgA, IgM, IgG4, IgE and ESR.